微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[62] 发布: 2014/07/22 08:47:46
MRO (press release) Global Market Report of Heparin sodium (CAS 9041-08-1) aims at providing comprehensive data on Heparin sodium globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Heparin sodium trends, pays close attention to Heparin  ... and more »
已读[73] 发布: 2014/07/22 08:47:38
TCTMD The HEAT-PPCI trial, published July 5, 2014, ahead of print in the Lancet, reports better efficacy and comparable safety with bivalirudin than heparin in patient...
已读[70] 发布: 2014/07/22 08:47:29
GMA News After tagging contaminated heparin as the cause of chills experienced by some patients at the National Kidney and Transplant Institute last May, Philippine health authorities have issued an advisory against two brands of the product. The Food and Drug ...
已读[62] 发布: 2014/07/22 08:47:12
GMA News The US National Institutes of Health defines heparin — a sodium solution used in dialysis machines — as a medication "used to prevent blood clots from forming in people who have certain medical conditions or who are undergoing certain medical ...
已读[68] 发布: 2014/07/22 08:47:01
Forbes 1,829 patients were randomized in the HEAT-PPCI trial to either heparin or bivalirudin. The results did not demonstrate any advantage for bivalirudin. There was...
已读[74] 发布: 2014/07/22 08:46:53
The Pharmaceutical Journal UK Medicines Information summarises the evidence for this frequently asked question: Should heparin -based solutions be used in preference to normal saline to prevent obstruction in indwelling intravascular catheters? Peripheral intravascular catheters ...
已读[67] 发布: 2014/07/22 08:46:46
Pharmacy Practice News Las Vegas—After implementing a collaborative process to deal with an increase in heparin infusion errors averaging nearly one per month, a commu...
已读[2854] 发布: 2014/07/10 09:28:55
  作为全球最大生猪饲养国,中国在肝素钠上游原料来源占有优势,曾在国际市场上占有60%的份额,然而近年来由于质量不达标导致欧美主要市场严重不信任等原因,近年来国际市场占比逐年下降,预计今年只有45%。欧美市场对肝素产品越来越严格,国外肝素工厂增多,抢夺中国肝素产品市场,种种因素导致中国肝素严重过剩,产业未来如何发展,肝素企业如何突破困...
已读[1154] 发布: 2014/07/10 09:26:28
7月7日,由世易科技举办的“2014第五届肝素钠360°产业论坛”在北京召开。会议吸引了常山药业、千红制药、兆科药业、天津红日药业、江南大学、洱天科技、北京东华强盛、、无锡思清源、仰韶生化等百余位肝素钠原料药生产商、供应商、科研机构院校、研究机构人员参加,业内菁英齐聚京城,聚焦肝素行业圈,共同探讨市场走向、技术革新以及产业的未来发展之路! &#...
已读[1264] 发布: 2014/07/01 07:32:29
海普瑞在投资者互动平台上表示,天道医药本次通过FDA认证的产品是普通的肝素制剂,并非注入条件中约定的低分子肝素制剂,所以目前天道医药注入海普瑞的条件并未达成。 ...
« 上一页  |   查看结果1381-1390共2625   |  下一页 »



最新报告


求职招聘